✦ LIBER ✦

Testing the SF-36 in Parkinson's disease

✍ Scribed by P. Hagell; A. L. Törnqvist; J. Hobart

Book ID: 106093874
Publisher: Springer
Year: 2008
Tongue: English
Weight: 328 KB
Volume: 255
Category: Article
ISSN: 0340-5354
DOI: 10.1007/s00415-008-0708-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The factor structure of the SF-36 in Par

The factor structure of the SF-36 in Parkinson's disease

✍ Pauline Banks; Colin R. Martin 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

PND49 MEASUREMENT CHARACTERISTICS OF THE

PND49 MEASUREMENT CHARACTERISTICS OF THE SF-36 IN PARKINSON'S DISEASE

✍ Banks, P.; Martin, C.R. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Genetic testing in Parkinson's disease

✍ Aideen McInerney-Leo 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

iology was found. Our case documents the occurrence of this unusual myoclonus physiology in biopsy-proven Lafora disease. Indeed, the movement disorder neurophysiology evaluation was more useful in terms of defining a myoclonus physiology than routine EEG. Wilkins and colleagues 4 first described t

Genetic testing in Parkinson's disease

✍ Aideen McInerney-Leo; Donald W. Hadley; Katrina Gwinn-Hardy; John Hardy 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

## Abstract Parkinson's disease (PD) is a common neurodegenerative disorder of adulthood characterized clinically by rigidity, bradykinesia, resting tremor, and postural instability. The annual incidence of PD ranges between 16 and 19 individuals per 100,000 (Twelves et al., Mov Disord 2003;18:19–3

THE PROBENECID TEST IN PARKINSON'S DISEA

THE PROBENECID TEST IN PARKINSON'S DISEASE

✍ Bowers, M.B.; Woert, M.H.Van 📂 Article 📅 1972 🏛 The Lancet 🌐 English ⚖ 278 KB

The Levodopa Test in Parkinson's Disease

✍ D'COSTA, D. F.; SHEEHAN, L. J.; PHILLIPS, P. A.; MOORE-SMITH, B. 📂 Article 📅 1995 🏛 Oxford University Press 🌐 English ⚖ 265 KB